LexDanaLexDanabeta
Inventor

SAMMY R. SHAVER

Inventor
US

Overview

3→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07DHeterocyclic compounds43%
A61KPreparations for medical, dental or toiletry purposes14%
PatentTitleYear
12,458,642Metalloenzyme inhibitor compounds202511,919,883Metalloenzyme inhibitor compounds202411,136,309Metalloenzyme inhibitor compounds2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021Patents assigned to PHASEBIO PHARMACEUTICALS INC (1)· patent assignee history
2021–2025Based in US· patent location history
2024–2025Patents assigned to JI XING PHARMACEUTICALS HONG KONG LTD (2)· patent assignee history
2025Patents assigned to CORXEL PHARMACEUTICALS HONG KONG LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JI XING PHARMACEUTICALS HONG KONG LTD22024–2025
CORXEL PHARMACEUTICALS HONG KONG LTD12025
PHASEBIO PHARMACEUTICALS INC12021
Locations
LocationPatentsSpan
US32021–2025